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Summary
In the present study, we showed that activation of human CD4 T cells can be induced by anti-
CD3 and collagen in a serum-free system. This activation was inhibited by the addition ofpeptides
containing the RGD or Gly-Pro-X sequences. Significantly, we demonstrated that both the 1177
(CD26) structure and the VLA integrin family, particularly the VLA3 complex, contribute to
the functional interaction between collagen and CD4 cells since anti-1177 and antiVLA3 specifically
inhibited this collagen-induced CD4 cell activation. Biochemical studies showed that the 1177
structure is not a member of the VLA integrin family. These results thus indicated that two
different families of antigens serve as functional collagen receptors for CD4 T cell activation.
indingof mAbs specific for the CD3/TCR complex can
activate human T cells and lead to the biological expres-
sion of the T cell functional program (1). However, while
recent studies have shown that such receptors for extracel-
lular matrix proteins as members of the integrin family (2,
3) may play important roles in cellular adhesion and migra-
tion, their role in immune response has yet to be clearly es-
tablished. Another structure with unknown immunologic
role that is also involved in cellular adhesion to extracellular
matrix proteins is dipeptidyl peptidase IV (DPPIV). Found
on a number of tissue types, DPPIV (CD26) is a membrane-
associated intrinsic ectoenzyme that has a binding affinity
for collagen (4-6). We have recently developed a mAb called
anti-1177, which recognizes the CD26 antigen on the surface
of a subset of human T lymphocytes (7, 8) . We previously
showed that fibronectin can synergize with anti-CD3 to pro-
mote CD4 cell proliferation in a serum-free culture system
(9). In the present study, we extended our studies of the role
of extracellular matrix proteins in human T cell function by
focusing on the interaction between collagen and its receptors
in CD4 T cell activation.
Materials and Methods
Cells and Reagents.
￿
Highly purified human CD4 T cells were
obtained as described previously (8, 9). Collagen I, III, and IV,
and BSA were from Sigma Chemical Co., St. Louis, MO. Laminin
was from Collaborative Research, Bedford, MA. Antibodies reac-
tive against T cell surface antigens used in this paper were described
previously (7-9). AntiVLA2 (12171) was obtained from Drs. K.
Pischel and V Woods, University ofCalifornia, San Diego; anti-
UCHL1 was from Dr. P. Beverley, Imperial Cancer Research Fund,
United Kingdom; antiVLA-5 (mAb 16) from Dr. K. Yamada, Na-
tional Institutes of Health, Bethesda, MD. Anti-VLA-3 Q143), a
gift from Dr. A. Albino, Memorial Sloan-Kettering Cancer Center
(New York, NY), was in ascites form and was extensively dialyzed
against PBS before experimentation. Peptides containing the Gly-
Pro-X sequences were from SigmaChemical Co. RGD-containing
peptides were from Telios Pharmaceuticals, San Diego, CA.
Proliferation Assays.
￿
Proliferation assays were done as described
earlier (9). For inhibition studies, cells were incubated with all tested
antibodiesor peptides for 30 min in 37°C before culture and then
placed in 96-well plates for proliferation assay. Data are expressed
as mean of triplicate samples and are representative of three sepa-
rate experiments. Each standard error was <15%. ['H]Thymidine
incorporation for cells incubated with collagen alone was <500 cpm.
Biochemical Analyses.
￿
For Fig. 3 a, T lymphocytes were stimu-
lated with PHA (0.25 Ag/ml) and rI1r2 (40 U/ml) (Biogen, Cam-
bridge, MA) for 10 d, while for Fig. 3 b, resting CD4 cells were
used after being prepared as described earlier. Biochemical analyses
were then done as described previously (7, 9). All samples were
analyzed under reducing conditions.
Results and Discussion
Inhibition ofAnti-CD3 plus Collagen-induced Human CD4
T Cell Activation by Anti-1177andAnti-4B4 (CD29) mAbs. As
shown in Fig. 1 a, when combined with anti-CD3 antibody
(0.1 ug/ml), collagen types I, 111, and IV could elicit CD4
cell proliferation, with collagen type I beingmost synergistic,
while anti-CD3 or collagen alone cannot elicit such activa-
tion. We then examined whether the interaction of collagen
with an integrin receptor or other class(es) of molecule on
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￿
Anti-CD3 plus collagen-induced activation of human
CD4 T cells is inhibitable by antibodies recognizing 1177 and the
VLA family of integrin receptors. (a) Collagen can induce prolifera-
tion ofCD4 cells in combination with anti-CD3 (0 .1 Wg/ml) . When
purified CD4 cells were cultured with anti-CD3 antibody alone in
serum-free media, there was no proliferation above background, using
antibody concentration of up to 5 wg/ml . (b) Inhibition of anti-CD3
Plus collagen-induced proliferation by anti-1177 and anti-4134 . Addition
of anti-1177 or anti-4134 at culture initiation inhibited proliferation of
CD4 cells incubated in a serum free culture system in the presence of
anti-CD3 (0 .1 ug/ml) and type I collagen (2 14g/ml) . (c) Inhibition
of anti-CD3 plus collagen-induced proliferation by antiVLA-3 but
not antiVLA-2 . Addition of antiVLA-3 but not antiVLA-2 anti-
bodies at culture initiation inhibited proliferation of CD4 cells in-
cubated in a serum-free culture system in the presence of anti-CD3
(0 .1 Wg/ml) and type I collagen (2 t~g/ml) .
CD4 cellswas required for the observed cell activation . Since
anti-4134 (CD29) antibody (10) reacts with the common /3
subunit associated with several ci subunits of the VLA inte-
grin family, we undertook experiments to determine whether
anti-4134 and antibodies recognizing other surface structures
could modulate the activation ofCD4 cells . In Fig. 1 b, ad-
dition of anti-4134 as well as anti-1177, but not control anti-
bodies, at culture initiation could markedly inhibit the anti-
CD3 plus type I collagen-induced CD4 cell proliferation,
although the inhibitory effect of anti-1177 was slightly less
than that of anti-4134 in most donors tested . In addition, in-
cubation with antiTal antibody, which recognized the similar
structure (CD26) defined by anti-1177 (7), showed virtually
no inhibition of this CD4 cell activation, although some
moderate inhibition was occasionally observed when higher
antiTal antibody concentrations (>10 jAg/ml) were used (data
not shown) . Since theVLA2 and VLA3 molecules of the
VLA integrin family have been proposed to be collagen re-
ceptors (3), we next determined which members of theVLA
family are actually involved in the synergistic activation of
CD4 cellsby anti-CD3 and collagen type I . In Fig . 1 c, addi-
tion of antiVLA-3 and anti-4134 at culture initiation could
inhibit CD4 cell proliferation in the presence of anti-CD3
and collagen type I in a dose-dependent fashion . AntiVLA3
and anti-1177 did not inhibit CD4 cell activation in the pres-
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ence ofCD3 plus fibronectin while, as previously described
(9), both antiVLA-5 and anti-4134 inhibited CD4 cell acti-
vation by anti-CD3 plus fibronectin (data not shown) . To-
gether, these results suggested that both VLA-3 and 1177 are
ofkey importance in humanCD4 lymphocyte activation in-
duced by anti-CD3 plus collagen . It is still possible that while
the particular antiVLA-2 antibody used in these experiments
did not inhibit this collagen-induced activation, other anti-
VLA-2 antibodies recognizing different epitopes may have
an inhibitory effect . Due perhaps to the general nature of
the low-affinity binding between collagen and its receptors
(11, 12), interactions of collagen with both VLA-3 and 1177
may be required for collagen-induced activation, and disrup-
tion of collagen binding to either VLA3 or 1177 by the addi-
tion of the respective antibodies results in virtually complete
inhibition ofthe functional response ofCD4 cells to collagen .
Inhibition of Anti-CD3 plus Collagen-induced CD4 T Cell
Activation by Peptides Containing RGD or GlyProX Sequences.
Many of the integrin receptors recognize sites that include
the tripeptide Arg-GlyAsp (RGD), a sequence that iscommon
tomany extracellular matrix proteins, including collagen, and
which is thought to play a key role in cell adhesion and
spreading (2, 13, 14) . As shown in Fig . 2 a, when the hex-
apeptide Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) containing the
RGD sequence was added to cell cultures, proliferation of
CD4 cells in response to anti-CD3 plus type I collagen was
inhibited in a dose-dependent fashion . In contrast, no inhi-
bition was observed with the related control hexapeptides
GRGESP and GRADSP. The central structure of collagen
can be regarded as being composed of repeating tripeptides
with the general structure Gly-XY where X is preferentially
proline and Y is preferentially 4-hydroxyproline (15), and pep-
tides containing this sequence have been shown to be involved
in collagen-induced cell adhesion (5, 6, 12) . As shown in Fig .
2 b, this CD4 cell activation was also inhibited by the addi-
b
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￿
Inhibition of anti-CD3 plus collagen-induced prolifera-
tion of CD4 T cells by peptides containing RGD or Gly-Pro-X se-
quences. (a) Proliferation of CD4 T cells cultured in anti-CD3 (0 .1
14g/ml) plus type I collagen (2 hg/ml)-coated wells in a serum-free
system was inhibited by GRGDSP but not GRGDSP or GRGESP
peptides. (b) Proliferation of CD4 T cells cultured in similar condi-
tions as a was inhibited by GlyProGlyGly, GIyProAla, and
G1yPro0HPro but not GIyGlyGly and GlyGlyVal peptides .
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10 V1tion of G1yProAla, G1yProGlyGly, and GlyProOHPro, but
not GIyGlyGly and G1yG1yVa1 . Significantly, the addition of
peptides containing the GlyProX sequences does not inhibit
CD4 cell activation in the presence of fibronectin and anti-
CD3, while the addition of peptides containing the RGD
sequence does not inhibit CD4 cell proliferation induced by
anti-CD3 plusPMA or anti-CD3 plus ID2 (data not shown) .
Together, the above results suggested that peptides that in-
clude the RGD and G1yProX sequences contain important
sites for the interaction of collagen with CD4 lymphocytes .
The IF7 Molecule and VLA Integrin Family Belong to Dis-
tinct Families ofStructures. In view of the inhibitory effects
on cell-collagen interaction exhibited by antibodies recog-
nizing the 1F7 structure and theVLA integrin family, struc-
tural comparison of 1F7 and the VLA integrin family was
done bySDS-PAGE . From lysates ofPHAstimulatedT cells,
anti-1F7 antibody precipitated the diffuse single band of the
110-kD glycoprotein, and anti-4B4 precipitated the diffuse
band of 130--135-, the 165-, and 185-kD glycoproteins,
as previously described (7, 9) . Anti-VLA2 and anti-VLA3
antibodies precipitated the 130- plus 165-kD and the 130-
plus 135-kD glycoproteins, respectively (Fig . 3 a) . Since it
is still possible that cell surface structures may be altered after
T cell activation,we then performed sequentialimmunopre-
cipitation using lysates from resting CD4 T cells to exclude
this possibility. Data from these studies showed that there
was no crossreaction between anti-1F7 and anti-4B4 antibodies
(Fig. 3 b) . The above results thus indicated that the 1F7 mol-
ecule and VLA integrin family belong to distinct families
of structures.
In this paperwe thus demonstrated that the 1F7 molecule
and the VLA integrin family are functional collagen receptors
on human CD4 cells . Anti-1F7, as well as anti-4B4, also
prevented the adhesion and spreading of mesothelioma cells
on plastic wells coated with collagen (data not shown) . It
is important to note that anti-IF7 recognizes the CD26 an-
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T cell surface structure recognized by anti-IF7 is
different from the members of the VLA integrin family. (Lane 1)
Anti-CD1 as negative control; (lane 2) anti-1F7 ; (lane 3) anti-4B4;
(lane 4) antiVLA-2; (lane 5) antiVLA-3 . (b) Lanes 1 and 2 were
precleared by anti-CD1 as controls . Lanes 3 and 4 were precleared by
anti-1F7, and lanes 5 and 6 were precleared by anti-4B4 . (Lanes 1, 3,
and 5 were precipitated by anti-1F7 after preclearing ; lanes 2, 4, and
6 were precipitated by anti-4B4 after preclearing.
tigen, which includes the structure recognized by antiTat and
anti-DPPIV antibodies . Recently, Hanski et al. demonstrated
that rat liver DPPIV has a binding affinity for collagen (6),
while Bauvois reported that mouse fibroblast DPPIV may
be a collagen-binding protein (5) . While further studies are
required to determine whether 1F7 andVLA-3 are two inde-
pendent collagen receptors onhuman CD4 T cells or whether
either molecule serves as an accessory molecule that facili-
tates collagen binding to its receptor, the identification of
the 1F7 antigen as a functional collagen receptor, one dis-
tinct from the VLA integrin family, suggests the existence
of distinct classes offunctional collagen receptors that mediate
collagen-dependent T cell function.
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